Billionaire investor Stanley Druckenmiller increased holdings in Amazon and Alphabet while making genetic testing firm Natera his largest position in Q2.
Billionaire investor Stanley Druckenmiller expanded his stakes in Amazon and Alphabet during Q2, but his largest holding was genetic testing company Natera, valued at $696.6 million. The position represents nearly one-fifth of his portfolio, signaling strong conviction in the mid-cap diagnostics firm over tech giants like Nvidia.
Natera specializes in cell-free DNA testing, offering products for pregnancy screening, cancer recurrence tracking, and transplant monitoring. Unlike consumer-focused brands, its revenue stems from clinical diagnostics, including tests like Signatera for oncology and Prospera for organ transplants.
Druckenmiller’s shift toward Natera contrasts with his traditional macro-focused investments, drawing attention to the company’s growth potential in molecular diagnostics. The move highlights a strategic bet on healthcare innovation over established tech leaders.